The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 20, 2022
Filed:
Nov. 09, 2018
Applicant:
Pfizer Inc., New York, NY (US);
Inventors:
Manfred Kraus, San Diego, CA (US);
Pei-Pei Kung, San Diego, CA (US);
Thomas Andrew Paul, San Diego, CA (US);
Shikhar Sharma, San Diego, CA (US);
Dominique Verhelle, Boston, MA (US);
Assignee:
Pfizer Inc., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4725 (2006.01); A61P 35/00 (2006.01); A61K 33/243 (2019.01); A61K 31/357 (2006.01); A61K 31/4412 (2006.01); A61K 31/4433 (2006.01); A61K 31/4545 (2006.01); A61K 31/496 (2006.01); A61K 31/501 (2006.01); A61K 31/5355 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4725 (2013.01); A61K 31/357 (2013.01); A61K 31/4412 (2013.01); A61K 31/4433 (2013.01); A61K 31/4545 (2013.01); A61K 31/496 (2013.01); A61K 31/501 (2013.01); A61K 31/5355 (2013.01); A61K 33/243 (2019.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01);
Abstract
This invention relates to combination therapies comprising an EZH2 inhibitor and a chemotherapeutic agent, and associated pharmaceutical compositions, methods of treatment, and pharmaceutical uses.